Stockscreener 앱 받기
87.25
1.65%
1.293
전일 마감가:
$85.96
열려 있는:
$85.78
하루 거래량:
470.11K
Relative Volume:
0.42
시가총액:
$10.73B
수익:
-
순이익/손실:
$-507.65M
주가수익비율:
-22.51
EPS:
-3.876
순현금흐름:
$-616.24M
1주 성능:
-5.72%
1개월 성능:
-24.31%
6개월 성능:
+18.64%
1년 성능:
+72.14%
1일 변동 폭
$85.33
$88.23
1주일 범위
$84.52
$92.00
52주 변동 폭
$48.24
$121.06
백스사이트 Stock (PCVX) Company Profile
명칭
Vaxcyte Inc
전화
650-837-0111
주소
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PCVX | 87.04 | 10.73B | 0 | -507.65M | -616.24M | -3.876 |
| VRTX | 448.26 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.88 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.97 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.80 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.82 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
백스사이트 Stock (PCVX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-07 | 개시 | Mizuho | Buy |
| 2023-04-18 | 개시 | TD Cowen | Outperform |
| 2023-01-03 | 재확인 | Needham | Buy |
| 2022-12-15 | 개시 | Guggenheim | Buy |
| 2022-11-17 | 개시 | BTIG Research | Buy |
| 2021-12-29 | 재개 | Jefferies | Buy |
| 2021-06-24 | 재개 | Jefferies | Buy |
| 2020-07-07 | 개시 | BofA Securities | Buy |
| 2020-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 개시 | Needham | Buy |
모두보기
백스사이트 주식(PCVX)의 최신 뉴스
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Principal Financial Group Inc. Purchases 34,287 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Jennison Associates LLC Decreases Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) is First Turn Management LLC's 5th Largest Position - MarketBeat
Victory Capital Management Inc. Has $29.14 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Curi RMB Capital LLC Purchases New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Los Angeles Capital Management LLC Takes $1.02 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte (NASDAQ:PCVX) Sees Large Volume IncreaseStill a Buy? - MarketBeat
RA Capital Management, L.P. Increases Stake in Vaxcyte Inc - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Vaxcyte Inc Shares - GuruFocus.com
Long Term Trading Analysis for (PCVX) - Stock Traders Daily
Vaxcyte Enters Oversold Territory (PCVX) - Nasdaq
FMR LLC Adjusts Stake in Vaxcyte Inc - GuruFocus.com
Vaxcyte provides regulatory updates on VAX-31 programs - TipRanks
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 By Investing.com - Investing.com Canada
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 - Investing.com
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - The Bakersfield Californian
Vaxcyte's VAX-31 Vaccine Secures FDA Breakthrough Status, Targets 95% Disease Coverage | PCVX Stock News - StockTitan
WCM Investment Management LLC Has $15.94 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Lisanti Capital Growth LLC Purchases 13,175 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Cantor Fitzgerald Increases Earnings Estimates for Vaxcyte - MarketBeat
TimesSquare Capital Management LLC Buys New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $245,803.74 in Stock - MarketBeat
Vaxcyte CEO Grant Pickering sells $245,796 in company stock - Investing.com India
Vaxcyte CEO Grant Pickering sells $245,796 in company stock By Investing.com - Investing.com Australia
FY2024 EPS Estimates for Vaxcyte Raised by Leerink Partnrs - MarketBeat
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely - Yahoo Finance
Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges - TipRanks
Vaxcyte's (PCVX) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Vaxcyte's (PCVX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Vaxcyte stock target lifted as analyst sees VAX-31 leading in clinical advancement - Investing.com UK
Leerink Partners reaffirms Outperform on Vaxcyte stock with bullish pipeline outlook - Investing.com UK
Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus.com
Vaxcyte Reports Progress and Strengthens Financial Position - TipRanks
Vaxcyte Inc (PCVX) Reports Q3 2024 Net Loss of $103.1 Million Am - GuruFocus.com
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
Vaxcyte's VAX-31 Vaccine Shows Promise in Phase 1/2, Plans Phase 3 Amid $3.3B Cash Position | PCVX Stock News - StockTitan
Vaxcyte, Inc. (NASDAQ:PCVX) COO Jim Wassil Sells 8,000 Shares - MarketBeat
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million By Investing.com - Investing.com Australia
Vaxcyte COO Jim Wassil sells $854k in stock - Investing.com
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million - Investing.com
Vaxcyte COO Jim Wassil sells $854k in stock By Investing.com - Investing.com UK
Harbor Capital Advisors Inc. Has $7.39 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Should You Consider Investing in Vaxcyte (PCVX)? - Insider Monkey
Raymond James & Associates Buys 11,798 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte’s stock flat as biotech preps to complete $1.42 billion stock offering - MSN
Vaxcyte (NASDAQ:PCVX) Trading Down 5.9%Time to Sell? - MarketBeat
China Universal Asset Management Co. Ltd. Grows Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Novo Holdings A S Has $85.70 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
백스사이트 (PCVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
백스사이트 주식 (PCVX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW | PRESIDENT AND CFO |
Nov 18 '24 |
Sale |
85.81 |
8,000 |
686,518 |
109,491 |
0.42%
0.16%
자본화:
|
볼륨(24시간):